Candice Junge

1.8k total citations
17 papers, 1.1k citations indexed

About

Candice Junge is a scholar working on Surgery, Molecular Biology and Hematology. According to data from OpenAlex, Candice Junge has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Candice Junge's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Protease and Inhibitor Mechanisms (3 papers) and Biomedical Ethics and Regulation (2 papers). Candice Junge is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Protease and Inhibitor Mechanisms (3 papers) and Biomedical Ethics and Regulation (2 papers). Candice Junge collaborates with scholars based in United States, South Korea and Germany. Candice Junge's co-authors include Stephen F. Traynelis, Melissa B. Gingrich, Polina Lyuboslavsky, Daniel J. Brat, Guido Mannaioni, C. Justin Lee, John R. Hepler, Sudar Alagarsamy, P. Jeffrey Conn and Pak H. Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Candice Junge

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candice Junge United States 12 437 329 246 240 193 17 1.1k
Claire Magnon France 15 546 1.2× 103 0.3× 155 0.6× 86 0.4× 443 2.3× 23 1.8k
Heinrich F. Bürgers Germany 12 425 1.0× 52 0.2× 214 0.9× 214 0.9× 75 0.4× 14 1.0k
Kazuo Kataoka Japan 16 197 0.5× 166 0.5× 212 0.9× 93 0.4× 215 1.1× 44 1.3k
Jens Strelau Germany 23 706 1.6× 95 0.3× 173 0.7× 84 0.3× 668 3.5× 33 2.4k
Carlos Salvador Spain 20 517 1.2× 278 0.8× 311 1.3× 85 0.4× 151 0.8× 39 1.3k
Sara Ribeiro United Kingdom 8 301 0.7× 183 0.6× 200 0.8× 93 0.4× 633 3.3× 9 1.1k
Konrad Oexle Germany 20 609 1.4× 70 0.2× 114 0.5× 83 0.3× 110 0.6× 63 1.3k
Sandrine Bichet Switzerland 10 323 0.7× 314 1.0× 100 0.4× 48 0.2× 109 0.6× 14 862
Marina Scarlato Italy 22 491 1.1× 72 0.2× 191 0.8× 81 0.3× 493 2.6× 43 1.3k
Wayne Tsang United States 9 427 1.0× 78 0.2× 93 0.4× 41 0.2× 178 0.9× 9 1.0k

Countries citing papers authored by Candice Junge

Since Specialization
Citations

This map shows the geographic impact of Candice Junge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candice Junge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candice Junge more than expected).

Fields of papers citing papers by Candice Junge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candice Junge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candice Junge. The network helps show where Candice Junge may publish in the future.

Co-authorship network of co-authors of Candice Junge

This figure shows the co-authorship network connecting the top 25 collaborators of Candice Junge. A scholar is included among the top collaborators of Candice Junge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candice Junge. Candice Junge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lane, Roger, Taher Darreh‐Shori, Candice Junge, et al.. (2024). Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers. BMC Neurology. 24(1). 116–116. 2 indexed citations
2.
Edwards, Amanda, Jessica Collins, Candice Junge, et al.. (2023). Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease. JAMA Neurology. 80(12). 1344–1344. 49 indexed citations
3.
Wolf, Nicole I., et al.. (2023). Pelizaeus-Merzbacher Disease: A Caregiver Assessment of Disease Impact. Journal of Child Neurology. 38(1-2). 78–84. 2 indexed citations
4.
Henry, Timothy D., Gary L. Schaer, Jay H. Traverse, et al.. (2016). Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study. Cell Transplantation. 25(9). 1701–1711. 49 indexed citations
5.
Povsic, Thomas J., Timothy D. Henry, Jay H. Traverse, et al.. (2016). The RENEW Trial. JACC: Cardiovascular Interventions. 9(15). 1576–1585. 85 indexed citations
6.
Losordo, Douglas W., et al.. (2013). IMPACT OF MOBILIZATION ABILITY ON CELL FUNCTIONALITY AND COMPARISON OF NORMAL AND CMI SUBJECT SAMPLES: AN ANALYSIS FROM ACT34–CMI. Journal of the American College of Cardiology. 61(10). E1817–E1817. 1 indexed citations
8.
Povsic, Thomas J., Douglas W. Losordo, Kenneth Story, et al.. (2012). Abstract 11770: Cardiac Biomarker Elevation during Stem Cell Mobilisation, Apheresis and Intramyocardial Delivery is Common but does not Impact Incidence of Long-Term MACE: An Analysis from ACT34-CMI. Circulation. 126. 1 indexed citations
9.
Povsic, Thomas J., Douglas W. Losordo, Kenneth Story, et al.. (2012). Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: An analysis from ACT34-CMI. American Heart Journal. 164(5). 689–697.e3. 14 indexed citations
10.
Losordo, Douglas W., Melina R. Kibbe, Farrell O. Mendelsohn, et al.. (2012). A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia. Circulation Cardiovascular Interventions. 5(6). 821–830. 133 indexed citations
11.
Han, K.S., Guido Mannaioni, Cecily E. Hamill, et al.. (2011). Activation of protease activated receptor 1 increases the excitability of the dentate granule neurons of hippocampus. Molecular Brain. 4(1). 32–32. 51 indexed citations
12.
Yuan, Hongjie, Katie M. Vance, Candice Junge, et al.. (2009). The Serine Protease Plasmin Cleaves the Amino-terminal Domain of the NR2A Subunit to Relieve Zinc Inhibition of the N-Methyl-d-aspartate Receptors. Journal of Biological Chemistry. 284(19). 12862–12873. 35 indexed citations
13.
Mannaioni, Guido, Anna G. Orr, Cecily E. Hamill, et al.. (2008). Plasmin Potentiates Synaptic N-Methyl-D-aspartate Receptor Function in Hippocampal Neurons through Activation of Protease-activated Receptor-1. Journal of Biological Chemistry. 283(29). 20600–20611. 59 indexed citations
14.
Junge, Candice, C. Justin Lee, Jeffrey J. Olson, et al.. (2004). Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Experimental Neurology. 188(1). 94–103. 137 indexed citations
15.
Junge, Candice, Taku Sugawara, Guido Mannaioni, et al.. (2003). The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proceedings of the National Academy of Sciences. 100(22). 13019–13024. 171 indexed citations
16.
Gingrich, Melissa B., Candice Junge, Polina Lyuboslavsky, & Stephen F. Traynelis. (2000). Potentiation of NMDA Receptor Function by the Serine Protease Thrombin. Journal of Neuroscience. 20(12). 4582–4595. 197 indexed citations
17.
Walther, I., et al.. (1986). Hybridoma cells produced by electrofusion in a homogeneous electric field. Acta Biotechnologica. 6(3). 287–291. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026